Stock Events

Stock Events

Imunon 

€1.86
79
+€0.02+1.09% Today

Statistics

Day High
1.87
Day Low
1.86
52W High
5.71
52W Low
1.78
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-1.04
-0.93
-0.82
-0.72
Expected EPS
-0.8503308
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBO0.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap166.82B
Gilead Sciences is a biopharmaceutical company that competes with Imunon in the development of treatments for infectious diseases, including HIV and hepatitis, areas where Imunon also aims to innovate.
Merck
MRK
Mkt Cap302.33B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including cancer treatments and vaccines, directly competing with Imunon's focus on oncology and immunotherapy.
Bristol-Myers Squibb
BMY
Mkt Cap121.42B
Bristol Myers Squibb operates in the same biopharmaceutical space as Imunon, focusing on cancer, HIV/AIDS, cardiovascular disease, and immune disorders, making it a direct competitor.
AMGEN
AMGN
Mkt Cap183.12B
Amgen is a biotech company focusing on human therapeutics, including treatments for cancer and inflammatory diseases, competing with Imunon's research and development in similar areas.
Pfizer
PFE
Mkt Cap147.62B
Pfizer is a global pharmaceutical corporation that competes with Imunon in the development and marketing of drugs and vaccines for a wide range of diseases, including those targeted by Imunon's pipeline.
Novartis
NVS
Mkt Cap290.05B
Novartis is a global healthcare company that competes with Imunon in developing innovative medicines for various diseases, including cancer and autoimmune diseases, areas of focus for Imunon.
Roche
RHHBY
Mkt Cap343.56B
Roche Holding AG is a healthcare company that competes with Imunon in the fields of pharmaceuticals and diagnostics, particularly in oncology and immunology.
Abbvie
ABBV
Mkt Cap381.1B
AbbVie is a research-based biopharmaceutical company that competes with Imunon in developing therapies for complex and serious diseases, including cancer and immune-mediated diseases.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson is a diversified healthcare company that competes with Imunon across several areas, including pharmaceuticals and research and development in immunology and oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap66.98B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious medical conditions, competing with Imunon in the area of immunotherapy and targeted cancer treatments.

About

Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Show more...
CEO
Michael Tardugno
Employees
27
Country
United States
ISIN
US15117N7012

Listings

STU
DE
CBO0.STU
F
DE
CBO0.F
MU
DE
CBO0.MU
LSE
GB
0HUZ.LSE

0 Comments

Share your thoughts

FAQ

What is Imunon stock price today?▼
The current price of CBO0.STU is €1.86 EUR — it has increased by +1.09% in the past 24 hours. Watch Imunon stock price performance more closely on the chart.
What is Imunon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Imunon stocks are traded under the ticker CBO0.STU.
When is the next Imunon earnings date?▼
Imunon is going to release the next earnings report on August 06, 2026.
What were Imunon earnings last quarter?▼
CBO0.STU earnings for the last quarter are -0.72 EUR per share, whereas the estimation was -1.04 EUR resulting in a +30.86% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Imunon have?▼
As of May 25, 2026, the company has 27 employees.
In which sector is Imunon located?▼
Imunon operates in the Manufacturing sector.
When did Imunon complete a stock split?▼
The last stock split for Imunon was on August 07, 2025 with a ratio of 1.15:1.
Where is Imunon headquartered?▼
Imunon is headquartered in Lawrence Township, United States.